Fresenius Medical Care

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$4,791,713
$4,881,454
$5,084,909
$4,760,162
Gross Profit
1,214,361
1,183,978
1,270,652
1,146,084
EBITDA
822,370
740,731
280,970
845,886
EBIT
447,135
346,368
259,395
479,630
Net Income
225,270
151,221
66,913
213,027
Net Change In Cash
4,791,713
4,881,454
5,084,909
4,760,162
Free Cash Flow
620,547
17,064
1,043,786
645,000
Cash
1,715,080
1,071,288
1,180,187
1,370,890
Basic Shares
586,826
586,826
586,826
586,826

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$19,335,909
$19,453,617
$19,398,000
$17,619,000
Gross Profit
4,756,652
4,925,005
5,310,000
5,077,000
EBITDA
3,206,227
3,209,626
1,580,000
3,549,136
EBIT
1,463,970
1,457,655
-140,135
1,963,769
Net Income
537,913
498,997
673,405
969,308
Net Change In Cash
19,335,909
19,453,617
19,398,000
17,619,000
Free Cash Flow
1,686,786
1,944,205
756,000
806,000
Cash
1,180,187
1,403,492
1,273,787
1,481,655
Basic Shares
586,826
586,826
586,492
586,130

Earnings Calls

Quarter EPS
2025-09-30
$0
2025-06-30
$0.91
2025-03-31
$0.42
2024-12-31
$0.45